| Ytd | -29.68% | |
| 1y | 37.97% |
| Open | 13.95 | Prev Close | 13.74 | Low | 13.30 | High | 14.03 | Mkt Cap | 322.47M |
| Vol | 696.14K | Avg Vol | 284.42K | EPS | -4.46 | P/E | -3.02 | Forward P/E | -35.12 |
| Beta | -0.21 | Short Ratio | 5.37 | Inst. Own | 37.24% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-29 | 50-d Avg | 16.08 | 200-d Avg | 18.23 | 1yr Est | 40.71 |
DBVT News
Châtillon, France, July 30, 2026 DBV Technologies Announces Sale of Approximately $50 Million of ADS
DBV Technologies is rated Buy following positive Phase 3 VITESSE results. My risk- and dilution-adju
DBV Technologies is rated a buy, with a 24% upside to a $17 FY 2027 price target as Viaskin nears BL
Châtillon, France, July 17, 2026 DBV Technologies Files At-The-Market (ATM) Prospectus for Up to $15
DBV Technologies S.A. (DBVT) Q2 2026 Earnings Call Transcript
DBV Technologies NASDAQ: DBVT said it is continuing preparations for a planned third-quarter 2026 Bi
Châtillon, France, July 16, 2026 DBV Te c hnologies Announces the Filing of its 2026 Half-Year Repor
DBV Technologies (NASDAQ:DBVT) reported quarterly losses of $(0.12) per share which missed the analy
Châtillon, France, July 16, 2026 DBV Technologies Reports Second Quarter and Half-Year 2026 Financia
Châtillon, France, July 14, 2026 DBV Technologies to Report Second Quarter 2026 Financial Results an
AMF Regulated Information Châtillon, France, July 6, 2026 Half-Year Report on the DBV Technologies L
DBV Technologies S.A. (DBVT) Discusses Regulatory Update and FDA Interactions for Viaskin Peanut Pat
Châtillon, France, June 29, 2026 DBV Technologies Provides BLA Submission Update for the VIASKIN® Pe
Châtillon, France, June 23, 2026 DBV Technologies Announces Inclusion in the Euronext Tech Leaders I
DBV Technologies (DBVT) saw its shares surge in the last session with trading volume being higher th
Châtillon, France, June 9, 2026 DBV Technologies Revises Participation in the Goldman Sachs 47th Ann
Châtillon, France, June 8, 2026 DBV Technologies to Present New Positive Data from VITESSE Study and
Châtillon, France, June 5, 2026 DBV Technologies to Participate in the Goldman Sachs 47th Annual Glo
Châtillon, France, June 3, 2026 DBV Technologies Announces the Results of its 2026 Combined General
Châtillon, France, June 2, 2026 DBV Technologies Announces First Participant Screened in THRIVE Phas
Châtillon, France, May 13, 2026 Combined General Meeting of June 3, 2026 Procedures for Obtaining In
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earning
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 30)
Stocks That Hit 52-Week Lows On Monday
Stocks That Hit 52-Week Lows On Thursday
Stocks Which Set New 52-Week Low The Last Trading Session, Fri., Dec. 7, 2018